Losartan Recall

Sandoz Inc., a prescription drug manufacturer, issued a voluntary nationwide recall of certain lot numbers of losartan tablets, a medicine which is used to treat high blood pressure.

Trace amounts of N-nitrosodimethylamine (NDMA), a probable human carcinogen, were found in the recalled products. The presence of NDMA is thought to be related to changes in the way the active substance was manufactured. To date, no adverse events related to this recall have been reported.

For more information about the recall, visit the U.S. Food & Drug Administration (FDA) website.

Horizon BCBSNJ is committed to providing you with the latest information to support the safe prescribing of medications